41.88
price down icon4.74%   -1.939
 
loading

Immunovant Inc (IMVT) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Operating Expenses
13.21%
114.36
131.76 127.22 115.74 94.28
Income/Loss From Continuing Operations Before Tax
13.36%
-109.08
-125.91 -119.70 -109.04 -87.07
Income Tax Expense/Benefit
161.28%
1.552
0.594 0.913 0.078 0.077
Income/Loss From Continuing Operations After Tax
12.54%
-110.64
-126.50 -120.61 -109.12 -87.15
Net Income/Loss
12.54%
-110.64
-126.50 -120.61 -109.12 -87.15
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.53%
181.51
173.64 170.87 146.47 146.09
Diluted Average Shares
4.53%
181.51
173.64 170.87 146.47 146.09
Basic Earnings Per Share
16.44%
-0.61
-0.73 -0.71 -0.74 -0.60
Diluted Earnings Per Share
16.44%
-0.61
-0.73 -0.71 -0.74 -0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$118.29
price down icon 2.45%
$103.00
price down icon 7.44%
$60.86
price down icon 1.73%
$234.50
price down icon 0.29%
ONC ONC
$366.50
price down icon 1.62%
$207.39
price down icon 6.31%
자본화:     |  볼륨(24시간):